MICROBOT MEDICAL INC. - COMMON STOCK

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

07 Jan 2025 13:15:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

06 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

30 Dec 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

10 Dec 2024 07:18:37 By Nasdaq GlobeNewswire

Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System

10 Dec 2024 05:00:00 By Nasdaq GlobeNewswire

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

15 Oct 2024 05:38:00 By Nasdaq GlobeNewswire

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

30 Sep 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

17 Sep 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

22 Aug 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

13 Aug 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

01 Aug 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

18 Jul 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

09 Jul 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

08 Jul 2024 05:20:00 By Nasdaq GlobeNewswire

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

03 Jul 2024 05:20:00 By Nasdaq GlobeNewswire

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

20 Jun 2024 05:25:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

17 Jun 2024 05:30:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

04 Jun 2024 13:20:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

03 Jun 2024 09:11:00 By Nasdaq GlobeNewswire

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

03 Jun 2024 05:20:00 By Nasdaq GlobeNewswire